Toshimitsu Hamasaki Selected Research

Adrenal Cortex Hormones (Corticosteroids)

1/2019	Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias.
10/2018	Japanese Antibacterial Drug Management for Cardiac Sarcoidosis (J-ACNES): A multicenter, open-label, randomized, controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshimitsu Hamasaki Research Topics

Disease

17	Myocardial Infarction 07/2019 - 10/2007
13	Sepsis (Septicemia) 10/2023 - 01/2011
12	Stroke (Strokes) 01/2022 - 01/2012
12	Heart Failure 10/2020 - 01/2012
11	Neoplasms (Cancer) 12/2019 - 10/2009
8	Hemorrhage 01/2022 - 04/2013
8	Atrial Fibrillation 01/2022 - 04/2014
8	Ischemic Stroke 01/2022 - 12/2014
8	Disseminated Intravascular Coagulation 02/2019 - 01/2011
7	Infarction (Infarctions) 01/2022 - 10/2007
6	Thrombosis (Thrombus) 02/2019 - 01/2011
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2015 - 07/2011
5	Infections 10/2023 - 11/2011
5	Transient Ischemic Attack 01/2022 - 06/2016
5	Wounds and Injuries (Trauma) 01/2019 - 11/2011
4	Lung Neoplasms (Lung Cancer) 12/2019 - 05/2015
3	Hepatocellular Carcinoma (Hepatoma) 05/2019 - 07/2014
3	Chronic Hepatitis C 05/2019 - 07/2014
3	Cerebral Infarction 01/2019 - 06/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 10/2018 - 01/2012
3	Hypertension (High Blood Pressure) 01/2018 - 01/2014
3	ST Elevation Myocardial Infarction 06/2016 - 02/2013
3	Chronic Limb-Threatening Ischemia 10/2015 - 02/2013
2	Bacterial Pneumonia 03/2024 - 09/2023
2	Cystic Fibrosis (Mucoviscidosis) 10/2023 - 12/2022
2	Bacteremia 05/2022 - 07/2012
2	Hemorrhagic Stroke 07/2021 - 06/2016
2	Embolic Stroke 07/2021 - 06/2016
2	Embolism (Embolus) 04/2021 - 06/2016
2	Osteonecrosis (Kienbock's Disease) 09/2020 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2018
2	Idiopathic Interstitial Pneumonias 01/2019 - 01/2017
2	Idiopathic Pulmonary Fibrosis 01/2019 - 01/2017
2	Tachycardia (Tachyarrhythmias) 01/2019 - 08/2017
2	Left Ventricular Dysfunction 01/2019 - 01/2018
2	Unstable Angina 10/2018 - 08/2017
2	Sarcoidosis (Schaumann Disease) 10/2018 - 01/2017
2	Cardiac Arrhythmias (Arrythmia) 08/2017 - 01/2012
2	Death (Near-Death Experience) 03/2017 - 10/2012
2	Tuberous Sclerosis (Bourneville's Disease) 07/2015 - 01/2013
2	Critical Illness (Critically Ill) 07/2015 - 02/2014
2	Stable Angina 01/2015 - 10/2014
2	Disease Progression 01/2015 - 12/2004
2	Hypotension (Low Blood Pressure) 04/2014 - 10/2007
2	Atrophy 01/2014 - 01/2014

Drug/Important Bio-Agent (IBA)

8	Dacarbazine (DIC)FDA LinkGeneric 02/2019 - 01/2011
6	AnticoagulantsIBA 01/2022 - 01/2011
6	RivaroxabanIBA 01/2022 - 06/2016
6	ThrombomodulinIBA 01/2019 - 01/2011
5	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 11/2011
4	InterferonsIBA 05/2019 - 07/2014
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2013
4	AdiponectinIBA 10/2018 - 08/2011
4	CytokinesIBA 09/2017 - 05/2011
4	Sirolimus (Rapamycin)FDA Link 07/2015 - 10/2014
3	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2021 - 12/2014
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2019 - 01/2017
3	Cytochrome P-450 CYP2C19IBA 01/2019 - 10/2014
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2014
3	SteroidsIBA 01/2017 - 11/2011
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2014
3	Indicators and Reagents (Reagents)IBA 12/2015 - 07/2011
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2015 - 07/2011
3	Sertraline (Zoloft)FDA LinkGeneric 04/2010 - 09/2005
2	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2016
2	landiololIBA 12/2019 - 04/2014
2	Fetal Proteins (Fetoprotein)IBA 05/2019 - 07/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 10/2018
2	CollagenIBA 05/2018 - 01/2014
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018 - 01/2013
2	Docosahexaenoic AcidsIBA 01/2018 - 01/2013
2	Eicosapentaenoic AcidIBA 01/2018 - 01/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 04/2014
2	Angiotensin Receptor AntagonistsIBA 01/2018 - 07/2014
2	Atrial Natriuretic Factor (ANF)IBA 01/2017 - 10/2007
2	EnzymesIBA 06/2016 - 01/2013
2	Ribavirin (Virazole)FDA LinkGeneric 03/2016 - 07/2014
2	BilirubinIBA 03/2016 - 02/2016
2	CholesterolIBA 02/2016 - 01/2014
2	trans-sodium crocetinate (crocetin)IBA 07/2015 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 01/2013
2	zotarolimusIBA 01/2015 - 10/2014
2	MetalsIBA 01/2015 - 10/2014
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2015 - 10/2014
2	Everolimus FDA Link 01/2015 - 10/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2014 - 05/2012
2	MicroRNAs (MicroRNA)IBA 07/2013 - 10/2012

Therapy/Procedure

26	Therapeutics 10/2023 - 01/2011
10	Percutaneous Coronary Intervention 07/2019 - 10/2007
7	Stents 07/2019 - 10/2014
5	Mechanical Ventilators (Ventilator) 03/2024 - 05/2012
4	Heart-Assist Devices 10/2020 - 03/2017
3	Drug-Eluting Stents 07/2019 - 10/2014
3	Secondary Prevention 10/2018 - 01/2014
2	Phage Therapy 10/2023 - 12/2022
2	Perioperative Period 12/2019 - 01/2017
2	Resuscitation 01/2019 - 10/2018
2	Chemoradiotherapy 10/2017 - 10/2014
2	Splenectomy 12/2015 - 07/2014
2	Drug Therapy (Chemotherapy) 12/2015 - 05/2012